Case of monkeypox confirmed in England
May 9, 2022Sales and Marketing
The UK Health Security Agency has confirmed that a person in England has been diagnosed with the monkeypox virus.The patient …
Shabir Hasham
May 6, 2022Shabir Hasham has served as Santhera’s Global Development Program Lead & Global Head Medical Affairs for the past three years, …
Shabir Hasham
May 6, 2022Shabir Hasham has served as Santhera’s Global Development Program Lead & Global Head Medical Affairs for the past three years, …
Allison Williamson
May 6, 2022BIOCAPTIVA has announced the appointment of Alison Williamson as Chief Financial Officer, and member of the board.Alison has over 30 …
Richard Laxer
May 6, 2022Richard Laxer joins Oxford Science Enterprises as an independent non-executive director. Richard is a veteran of GE Capital, serving the …
Dr Karen Mullen
May 6, 2022Dr Karen Mullen joins Boyds from GlaxoSmithKline, where, as Country Medical Director for UK and Ireland, she led and managed …
Appy Days: How the smartphone app is revolutionising mental healthcare
May 6, 2022Over the last decade, our individual awareness and understanding of mental health has risen to unprecedented levels. Despite its pitfalls, …
WHO launches first ever global report on Infection Prevention and Control
May 6, 2022Medical Communications
A new report from WHO has highlighted the importance of effective IPC programmes, and shown that where good hand hygiene …
Open Orphan to begin first-ever COVID-19 challenge trial
May 6, 2022Medical Communications
Open Orphan has been appointed by an unnamed existing “big pharma” client to host a Phase II field study of …
FDA narrows use of J&J vaccine due to blood clot risk
May 6, 2022Medical Communications
The FDA has limited the use of Johnson & Johnson’s coronavirus vaccine, to adults who cannot, or refuse to get, …
AstraZeneca’s heart disease drug meets key endpoints in Phase III
May 6, 2022Medical Communications
AstraZeneca’s treatment for heart disease has delivered positive high-level results from its Phase III DELIVER trial.Farxiga (dapagliflozin) is already approved …
First regenerative cell therapy for hearing loss
May 5, 2022Business Services
Rinri Therapeutics have announced the MHRA has awarded an innovation passport to the company’s lead candidate, Rincell-1. Rincell-1 is a …
Nearly three million people receive lifesaving NHS cancer checks
May 5, 2022Business Services
A record three million people received vital NHS cancer tests from March 2021 to February 2022, compared to 2.4 million …
Health experts report more symptoms of long COVID-19
May 5, 2022Business Services
According to health experts, many COVID-19 patients are still suffering the effects of the condition months after they first started …
FDA approval for first in vitro diagnostic for early Alzheimer’s detection
May 5, 2022Business Services
The US FDA has approved the first in vitro diagnostic to aid in the early detection of Alzheimer’s disease (AD). …
BLINCYTO approved in China for leukaemia treatment
May 4, 2022Research and Development
The China National Medical Products Administration (NMPA) has granted conditional approval of BLINCYTO (blinatumomab), as an injection for the treatment …
Amphista Therapeutics and Bristol Myers Squibb partner for development of protein degradation therapeutics
May 4, 2022Research and Development
Amphista and Bristol-Myers Squibb have announced a strategic collaboration and license agreement.Under the terms of the collaboration, BMS and Amphista …
Smartphone app could screen for Alzheimer’s disease
May 4, 2022Research and Development
Researchers at the University of California San Diego have developed a smartphone app with the potential to screen for Alzheimer’s …
WHO announce upcoming updates on treatment of drug-resistant tuberculosis
May 4, 2022Research and Development
A rapid communication released by WHO Global Tuberculosis Programme has announced upcoming updates to the guidance on the treatment of …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
